Skip to main content
Have a personal or library account? Click to login
Synthesis of pyranopyrazolo N-glycoside and pyrazolopyranopyrimidine C-glycoside derivatives as promising antitumor and antimicrobial agents Cover

Synthesis of pyranopyrazolo N-glycoside and pyrazolopyranopyrimidine C-glycoside derivatives as promising antitumor and antimicrobial agents

Open Access
|Sep 2015

References

  1. 1. E. De Clercq, Antiviral drugs in current clinical use,.(2004) 115–133; DOI: 10.1016/j.jcv.2004.02.009.
  2. 2. P. J. O’Dwyer, S. A. King, J. Plowman, C. K. Grieshaber, D. F. Hoth and B. Leyland-Jones, Pyrazole: preclinical reassessment,(1988) 305–310.
  3. 3. A. Bekhit and T. Abdel-Aziem, Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents,.(2004) 1935–1945; DOI: 10.1016/j.bmc.2004.01.037.
  4. 4. K. L. Kees, J. J. Fitzgerald, K. E. Steiner, J. F. Mattes, B. Mihan and T. Tosi, New potent antihyperglycemic agents in db/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and -pyrazolones,.(1996) 3920–3928.
  5. 5. A. Geronikaki, E. Babaev, J. Dearden, W. Dehaen, D. Filimonov, I. Galaeva, V. Krajneva, A. Lagunin, F. macaev, G. Molodavkin, V. Poroikov, S. Pogrebnoi, V. Saloutin, A. Stepanchikova, E. Stingaci, N. Tkach, L. Vlad and T. Voroninaf, Design, synthesis, computational and biological evaluation of new anxyiolytics,(2004) 6559–6568; DOI: 10.1016/j.bmc.2004.09.016.
  6. 6. D. Sil, R. Kumar, A. Sharon, P. R. Malik and V. Ram, Stereoselective alkenylation of a 1,3-disubstituted pyrazol-5-one through ring transformation of 2H-pyran-2-ones,(2005) 3807–3809; DOI: 10.1016/j.tetlet.2005.03.207.
  7. 7. J. S. Larsen, M. A. Zahran, E. B. Pedersen and C. Nielsen, Synthesis of triazenopyrazole derivatives as potential inhibitors of HIV-1,.(1999) 1167–1173.
  8. 8. A. Arrieta, J. R. Carrillo, F. P. Cossl, E. Ortiz, M. J. Gomez-Escalonilla, A. de la Hoz, F. Langa and A. Moreno, Efficient tautomerization hydrazone-azomethine imine under microwave irradiation. Synthesis of [4,3′] and [5,3′]bipyrazoles,(1998) 13167–13180; DOI: 10.1016/S0040-4020(98)00798-4.
  9. 9. G. M. Nitulescu, C. Draghici and O. T. Olaru, New potential antitumor pyrazole derivatives: Synthesis and cytotoxic evaluation,(2013) 21805–21818; DOI: 10.3390/ijms141121805.
  10. 10. J. L. Wang, D. Liu, Z. J. Zhang, S. Shan, X. Han, S. M. Srinivasula, C. M. Croce, E. S. Alnemri and Z. Huang, Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells,(2000) 7124–7129.
  11. 11. E. S. El-Tamany, F. A. El-Shahed and B. H. Mohamed, Synthesis and biological activity of some pyrazole derivatives,(1999) 9–18.
  12. 12. M. E. A. Zaki, H. S. Soliman, O. A. Hiekal and A. E. Rashad, Pyrazolopyranopyrimidines as a class of anti-inflammatory agents,..(2006) 1–5.
  13. 13. F. M. Abdelrazek, P. Metz, N. H. Metwally and S. F. El-Mahrouky, Synthesis and molluscicidal activity of new cinnoline and pyrano[2,3-]pyrazole derivatives,.(2006) 456–460.
  14. 14. F. M. Abdelrazek, P. Metz, O. Kataeva, A. Jager and S. F. EI-Mahrouky, Synthesis and molluscicidal activity of new chromene and pyrano[2,3-]pyrazole derivatives,(2007) 543–548.
  15. 15. N. Foloppe, L. M. Fisher, R. Howes, A. Potter, A. G. S. Robertson and A. E. Surgenor. Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening,(2006) 4792–4802; DOI: 10.1016/j.bmc.2006.03.021.
  16. 16. S. A. El-Assiery, G. H. Sayed and A. Fouda, Synthesis of some new annulated pyrazolo-pyrido (or pyrano) pyrimidine, pyrazolopyridine and pyranopyrazole derivatives,(2004) 143–150.
  17. 17. C. M. Ashraf, S. S. Ali and A. Hussain, Organic reaction in aqueous solution, Part-VIII: Effect of Sonication on the reaction of thiosemicarbazide with ethyl acetoacetate,(1998) 145–149.
  18. 18. M. M. H. Bhuiyan, M. I. Hossain, M. A. Alam and M. M. Mahmud, Microwave assisted Knoevenagel condensation: synthesis and antimicrobial activites of some arylidene-malononitriles,(2012) 31–37.
  19. 19. S. R. Jain and A. Kar, The antibacterial activity of some essential oils and their combinations.(1971) 118–123; DOI: 10.1055/s-0028-1099675.
  20. 20. H. Ericsson and J. C. Sherris, Antibiotic sensitivity testing. Report of an international collaborative study,(1971) 1–90.
  21. 21. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenny and M. R. Boyd, New colorimetric cytotoxicity assay for anticancer drug screening,.(1990) 1107–1112; DOI: 10.1093/jnci/82.13.1107.
  22. 22. A. Monks, D. Scudiero, P. Skehan, R. Shoemaker, K. Paul, D. Vistica, C. Hose, J. Langley, P. Cronise, A. Vaigro-Wolff, M. Gray-Goodrich, H. Campbell, J. Mayo and J. M. Boyd, Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines,.(1991) 757–776; DOI: 10.1093/jnci/83.11.757.
  23. 23. A. B. A. El-Gazzar, H. N. Hafez and G. A. M. Nawwar, New acyclic nucleoside analogues as potential analgesic, anti-inflammatory, anti-oxidant and anti-microbial derived from pyrimido[4,5-b]quinolines,(2009) 1427–1436; DOI: 10.1016/j.-ejmech.2008.09.030.
DOI: https://doi.org/10.1515/acph-2015-0022 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 215 - 233
Accepted on: Feb 17, 2015
Published on: Sep 30, 2015
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2015 Hend N. Hafez, Abdel-Rhman B. A. El-Gazzar, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.